Busulfex
Active substance: Busulfan
Manufacturer: PDL Biopharma
Extract from the prescribing information:
"Busulfan is a mutagen and a clastogen."
"Busulfan is a presumed human carcinogen."
"BUSULFEX should be administered under the supervision of a qualified physician experienced in hematopoietic stem cell transplantation."
The above has been extracted from the Busulfex prescribing information on the PDL Biopharma webpages.